Medical News Today: Menopause and heart health: Why timing hormone therapy is key

Researchers at the University of Guelph in Canada are the first to study how perimenopause affects heart health in female mice.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Menopause Source Type: news

Related Links:

FRIDAY, Oct. 18, 2019 -- Longer use of estrogen hormone therapy is associated with higher cognitive status in late life, according to a study published online Oct. 14 in Menopause. Joshua M. Matyi, from Utah State University in Logan, and colleagues...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Publication date: November 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 11Author(s): Susan R Davis
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research
PMID: 31612748 [PubMed - in process]
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
A study published inMenopause suggests hormone therapy may improve cognitive function and brain health in menopausal women.MedicalXpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
Publication date: Available online 14 October 2019Source: Case Reports in Women's HealthAuthor(s): Loukas Athanasiadis, Dimitrios G. Goulis
Source: Case Reports in Womens Health - Category: OBGYN Source Type: research
Conclusions: Acupuncture significantly alleviated menopause symptoms for at least 3 months, but not hot flushes. Breast cancer patients concerned about the adverse effects of hormone therapy could consider acupuncture as an alternative. Additional acupuncture at 3 months after the initial treatment course could be considered. A large-scale study may help to define the optimal guideline for this issue. PMID: 31612733 [PubMed - as supplied by publisher]
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
ConclusionFurther studies are needed to elucidate the nature of the association between menopause, sleep and persistent pain syndromes, such as FM, showing the role of hormone therapy in prospective placebo ‐controlled trials.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: REVIEW Source Type: research
Waseem Abbas, Ranga Raju RaoIndian Journal of Cancer 2019 56(4):293-296Adjuvant ovarian suppression, on addition to chemotherapy, reduces the risk of breast cancer in pre-menopausal women after surgery and adjuvant hormonal therapy. Suppression of Ovarian Function Trial (SOFT) and Tamoxifen and Exemestane Trial (TEXT) showed greater benefit with exemestane in high risk females in comparison to Tamoxifen. Ovarian Function Suppression (OFS) and exemestane became the standard of care, with 30% patients experiencing grade 3 and more side effects. Much higher benefit was seen in high risk group. But there are concerns about inc...
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
.
Source: Gynecological Endocrinology - Category: Endocrinology Authors: Source Type: research
Introduction: Recent evidence demonstrates that women with myotonic dystrophy type 1 are at increased risk of reproductive organ tumors. However, studies of reproductive cancer risk factors in those patients are lacking.Methods: Using questionnaires, we collected and analyzed personal history information related to cancer risk factors from women enrolled in a UK and US registry for myotonic dystrophy (dystrophia myotonica; DM) patients.Results: The survey was completed by 242 DM type 1 (DM1) and 44 DM type 2 (DM2) women enrolled in the UK Registry (N = 124) and the US National Registry (N = 162). The mean age at DM1 diagno...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Canada Health | Cardiology | Health | Heart | Hormonal Therapy | Hormones | Men | Menopause | Study